| 3515 |
2318: Decreased 3βHSD activity |
1611: Reduction, androstenedione |
Apr 8, 2025 |
Apr 8, 2025 |
None
|
| 3516 |
2318: Decreased 3βHSD activity |
1693: Decreased, Progesterone levels |
Apr 8, 2025 |
Apr 8, 2025 |
None
|
| 3517 |
447: Reduction, Cholesterol transport in mitochondria |
2319: Decreased, Pregnenolone levels |
Apr 8, 2025 |
Apr 8, 2025 |
None
|
| 3518 |
2320: Decreased, 17βHSD3 activity |
1690: Decrease, circulating testosterone levels |
Apr 8, 2025 |
Apr 8, 2025 |
None
|
| 3519 |
2321: Decreased, CYP11A1 activity |
2319: Decreased, Pregnenolone levels |
Apr 8, 2025 |
Apr 8, 2025 |
None
|
| 3520 |
2319: Decreased, Pregnenolone levels |
1610: Reduction, DHEA |
Apr 8, 2025 |
Apr 8, 2025 |
None
|
| 3521 |
1693: Decreased, Progesterone levels |
1611: Reduction, androstenedione |
Apr 8, 2025 |
Apr 8, 2025 |
None
|
| 3522 |
2319: Decreased, Pregnenolone levels |
1693: Decreased, Progesterone levels |
Apr 8, 2025 |
Apr 8, 2025 |
None
|
| 3569 |
1445: Increase, LPO |
1994: Ferroptosis |
Aug 13, 2025 |
Aug 13, 2025 |
None
|
| 3570 |
1634: Increase, Oxidative DNA damage |
1262: Apoptosis |
Aug 13, 2025 |
Aug 13, 2025 |
None
|
| 3575 |
2342: Fe-S cluster assembly, impaired |
1477: OXPHOS, decreased |
Aug 13, 2025 |
Aug 13, 2025 |
None
|
| 3532 |
36: Inhibition, Aromatase |
219: Reduction, Plasma 17beta-estradiol concentrations |
Apr 29, 2025 |
Apr 29, 2025 |
None
|
| 3535 |
2324: Dysregulation of Treg/Th17 cell ratio |
2325: Decreased number of LT CD8+ cells |
May 16, 2025 |
May 16, 2025 |
None
|
| 3581 |
2341: TCA cycle, disrupted |
1477: OXPHOS, decreased |
Aug 15, 2025 |
Aug 15, 2025 |
None
|
| 3539 |
2326: CTL cytotoxicity |
2325: Decreased number of LT CD8+ cells |
May 22, 2025 |
May 22, 2025 |
None
|
| 3542 |
2325: Decreased number of LT CD8+ cells |
1971: tumor growth |
Jun 10, 2025 |
Jun 10, 2025 |
None
|
| 3364 |
1445: Increase, LPO |
1505: Cell cycle disruption |
Oct 8, 2024 |
Oct 8, 2024 |
None
|
| 3377 |
1511: Lipid Peroxidation |
1442: Foam cell formation |
Oct 30, 2024 |
Oct 30, 2024 |
None
|
| 3379 |
2274: Androgen receptor activation, increased |
286: Altered, Transcription of genes by the AR |
Nov 2, 2024 |
Nov 24, 2024 |
None
|
| 3380 |
2272: Testosterone levels, increased |
2274: Androgen receptor activation, increased |
Nov 2, 2024 |
Nov 24, 2024 |
None
|
| 3381 |
2273: Dihydrotestosterone (DHT) levels, increased |
2274: Androgen receptor activation, increased |
Nov 2, 2024 |
Nov 24, 2024 |
None
|
| 3382 |
1392: Increase, Oxidative Stress |
1553: Increase mutations |
Nov 6, 2024 |
Nov 6, 2024 |
None
|
| 3362 |
1634: Increase, Oxidative DNA damage |
1505: Cell cycle disruption |
Oct 8, 2024 |
Oct 8, 2024 |
None
|
| 3361 |
1767: Increase, Protein oxidation |
55: Cell injury/death |
Oct 8, 2024 |
Oct 8, 2024 |
None
|
| 3360 |
1445: Increase, LPO |
55: Cell injury/death |
Oct 8, 2024 |
Oct 8, 2024 |
None
|